Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
Submitted by
admin
on June 15, 2016 - 11:11pm
Source:
BioPharma Dive
News Tags:
Merck
Pfizer
diabetes
clinical trials
ertugliflozin
Headline:
Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
Do Not Allow Advertisers to Use My Personal information
